Recently, we decided to tackle these challenges by trying to identify molecules, which could work as ‘anti-estrogen-like’ drugs by inducing ERα degradation and killing BC cells modeling the primary and the metastatic disease. This evidence concerns the gene ESR1 and metastatic neoplasm.